Instrument Inactif

Communiqués Pluristem Therapeutics Inc. Nasdaq

Actions

US72940R1023

Recherche biotechnologique et médicale

Communiqués

28/07	Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK	AQ
14/07	Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%	AQ
02/06	Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing	AQ
15/05	Pluri: Fiscal Q3 Earnings Snapshot	AQ
19/04	Pluri : Company deck – Q2 2026	PU
26/03	Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement	AQ
18/02	Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent	AQ
12/02	Pluri: Fiscal Q2 Earnings Snapshot	AQ
22/01	Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials	AQ
22/12	Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved	AQ
09/12	Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional Investment	AQ
13/11	Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year	AQ
12/11	Pluri: Fiscal Q1 Earnings Snapshot	AQ
11/11	Pluri : Company deck – Q4 2025	PU
11/11	Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare	AQ
10/11	Leading Global Players Back and Fund Pluri’s Cell-Based Food and Agriculture Collaborations	AQ
09/10/25	Pluri Subsidiary Coffeesai and Instituto del Cafe de Chiapas Announce Strategic Collaboration to Advance Cell Based Coffee Manufacturing in Mexico	AQ
08/10/25	Pluri Subsidiary Coffeesai and Instituto del Café de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico	AQ
18/09/25	Pluri : Company deck – Q3 2025	PU
10/08/25	Pluri : Company deck – Q3 2025	PU
01/07/25	Pluri : Company deck – Q3 2025	PU
15/05/25	Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion	AQ
13/05/25	Pluri: Fiscal Q3 Earnings Snapshot	AQ
05/05/25	Pluri : Company deck – Q2 2025	PU
28/04/25	Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd.	AQ